|
1
|
Jelovac D and Armstrong DK: Recent
progress in the diagnosis and treatment of ovarian cancer. CA
Cancer J Clin. 61:183–203. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Naora H and Montell DJ: Ovarian cancer
metastasis: Integrating insights from disparate model organisms.
Nat Rev Cancer. 5:355–366. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bowtell DD, Böhm S, Ahmed AA, Aspuria PJ,
Bast RC Jr, Beral V, Berek JS, Birrer MJ, Blagden S, Bookman MA, et
al: Rethinking ovarian cancer II: Reducing mortality from
high-grade serous ovarian cancer. Nat Rev Cancer. 15:668–679. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Karin M and Greten FR: NF-kappaB: Linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karin M, Cao Y, Greten FR and Li ZW:
NF-kappaB in cancer: From innocent bystander to major culprit. Nat
Rev Cancer. 2:301–310. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Min C, Eddy SF, Sherr DH and Sonenshein
GE: NF-kappaB and epithelial to mesenchymal transition of cancer. J
Cell Biochem. 104:733–744. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Malaponte G, Signorelli SS, Bevelacqua V,
Polesel J, Taborelli M, Guarneri C, Fenga C, Umezawa K and Libra M:
Increased levels of NF-kB-dependent markers in cancer-associated
deep venous thrombosis. PLoS One. 10:e01324962015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu K and Bonavida B: The activated
NF-kappaB-Snail-RKIP circuitry in cancer regulates both the
metastatic cascade and resistance to apoptosis by cytotoxic drugs.
Crit Rev Immunol. 29:241–254. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Storci G, Sansone P, Mari S, D'Uva G,
Tavolari S, Guarnieri T, Taffurelli M, Ceccarelli C, Santini D,
Chieco P, et al: TNFalpha up-regulates SLUG via the
NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a
stem cell-like phenotype. J Cell Physiol. 225:682–691. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Do SI, Kim JY, Kang SY, Lee JJ, Lee JE,
Nam SJ and Cho EY: Expression of TWIST1, Snail, Slug, and NF-κB and
methylation of the TWIST1 promoter in mammary phyllodes tumor.
Tumour Biol. 34:445–453. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Corson TW and Crews CM: Molecular
understanding and modern application of traditional medicines:
Triumphs and trials. Cell. 130:769–774. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Johnson JJ and Mukhtar H: Curcumin for
chemoprevention of colon cancer. Cancer Lett. 255:170–181. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sak K: Chemotherapy and dietary
phytochemical agents. Chemother Res Pract.
2012:2825702012.PubMed/NCBI
|
|
14
|
Li-Weber M: Targeting apoptosis pathways
in cancer by Chinese medicine. Cancer Lett. 332:304–312. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wong KF, Yuan Y and Luk JM: Tripterygium
wilfordii bioactive compounds as anticancer and anti-inflammatory
agents. Clin Exp Pharmacol Physiol. 39:311–320. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chiang KC, Tsui KH, Chung LC, Yeh CN, Chen
WT, Chang PL and Juang HH: Celastrol blocks interleukin-6 gene
expression via downregulation of NF-κB in prostate carcinoma cells.
PLoS One. 9:e931512014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dai Y, Desano J, Tang W, Meng X, Meng Y,
Burstein E, Lawrence TS and Xu L: Natural proteasome inhibitor
celastrol suppresses androgen-independent prostate cancer
progression by modulating apoptotic proteins and NF-kappaB. PLoS
One. 5:e141532010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shao L, Zhou Z, Cai Y, Castro P, Dakhov O,
Shi P, Bai Y, Ji H, Shen W and Wang J: Celastrol suppresses tumor
cell growth through targeting an AR-ERG-NF-κB pathway in
TMPRSS2/ERG fusion gene expressing prostate cancer. PLoS One.
8:e583912013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim Y, Kang H, Jang SW and Ko J: Celastrol
inhibits breast cancer cell invasion via suppression of
NF-kB-mediated matrix metalloproteinase-9 expression. Cell Physiol
Biochem. 28:175–184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li PP, He W, Yuan PF, Song SS, Lu JT and
Wei W: Celastrol induces mitochondria-mediated apoptosis in
hepatocellular carcinoma Bel-7402 cells. Am J Chin Med. 43:137–148.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rajendran P, Li F, Shanmugam MK, Kannaiyan
R, Goh JN, Wong KF, Wang W, Khin E, Tergaonkar V, Kumar AP, et al:
Celastrol suppresses growth and induces apoptosis of human
hepatocellular carcinoma through the modulation of STAT3/JAK2
signaling cascade in vitro and in vivo. Cancer Prev Res (Phila).
5:631–643. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang GZ, Liu YQ, Cheng X and Zhou GB:
Celastrol induces proteasomal degradation of FANCD2 to sensitize
lung cancer cells to DNA crosslinking agents. Cancer Sci.
106:902–908. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fan XX, Li N, Wu JL, Zhou YL, He JX, Liu L
and Leung EL: Celastrol induces apoptosis in gefitinib-resistant
non-small cell lung cancer cells via caspases-dependent pathways
and Hsp90 client protein degradation. Molecules. 19:3508–3522.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li HY, Zhang J, Sun LL, Li BH, Gao HL, Xie
T, Zhang N and Ye ZM: Celastrol induces apoptosis and autophagy via
the ROS/JNK signaling pathway in human osteosarcoma cells: An in
vitro and in vivo study. Cell Death Dis. 6:e16042015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ling C, Wang Y, Feng YL, Zhang YN, Li J,
Hu XR, Wang LN, Zhong MF, Zhai XF, Zolotukhin I, et al: Prevalence
of neutralizing antibodies against liver-tropic adeno-associated
virus serotype vectors in 100 healthy Chinese and its potential
relation to body constitutions. J Integr Med. 13:341–346. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bolshakova A, Magnusson KE, Pinaev G and
Petukhova O: Functional compartmentalisation of NF-kB-associated
proteins in A431 cells. Cell Biol Int. 37:387–396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ni H, Zhao W, Kong X, Li H and Ouyang J:
NF-kappa B modulation is involved in celastrol induced human
multiple myeloma cell apoptosis. PLoS One. 9:e958462014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zanotto-Filho A, Braganhol E, Battastini
AM and Moreira JC: Proteasome inhibitor MG132 induces selective
apoptosis in glioblastoma cells through inhibition of PI3K/Akt and
NFkappaB pathways, mitochondrial dysfunction and activation of
p38-JNK1/2 signaling. Invest New Drugs. 30:2252–2262. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yadav VR, Sung B, Prasad S, Kannappan R,
Cho SG, Liu M, Chaturvedi MM and Aggarwal BB: Celastrol suppresses
invasion of colon and pancreatic cancer cells through the
downregulation of expression of CXCR4 chemokine receptor. J Mol Med
(Berl). 88:1243–1253. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiang L, Wu J, Yang Y, Liu L, Song L, Li J
and Li M: Bmi-1 promotes the aggressiveness of glioma via
activating the NF-kappaB/MMP-9 signaling pathway. BMC Cancer.
12:4062012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jin J, Shen X, Chen L, Bao LW and Zhu LM:
TMPRSS4 promotes invasiveness of human gastric cancer cells through
activation of NF-κB/MMP-9 signaling. Biomed Pharmacother. 77:30–36.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu Z, Ma L and Zhou GB: The main
anticancer bullets of the Chinese medicinal herb, thunder god vine.
Molecules. 16:5283–5297. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ou CC, Chen YW, Hsu SC, Sytwu HK, Loh SH,
Li JW and Liu JY: Triptolide transcriptionally represses HER2 in
ovarian cancer cells by targeting NF-κB. Evid Based Complement
Alternat Med. 2012:3502392012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao H, Yang Z, Wang X, Zhang X, Wang M,
Wang Y, Mei Q and Wang Z: Triptolide inhibits ovarian cancer cell
invasion by repression of matrix metalloproteinase 7 and 19 and
upregulation of E-cadherin. Exp Mol Med. 44:633–641. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee JH, Won YS, Park KH, Lee MK, Tachibana
H, Yamada K and Seo KI: Celastrol inhibits growth and induces
apoptotic cell death in melanoma cells via the activation
ROS-dependent mitochondrial pathway and the suppression of PI3K/AKT
signaling. Apoptosis. 17:1275–1286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kang H, Lee M and Jang SW: Celastrol
inhibits TGF-β1-induced epithelial-mesenchymal transition by
inhibiting Snail and regulating E-cadherin expression. Biochem
Biophys Res Commun. 437:550–556. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chakravarthy R, Clemens MJ, Pirianov G,
Perdios N, Mudan S, Cartwright JE and Elia A: Role of the eIF4E
binding protein 4E-BP1 in regulation of the sensitivity of human
pancreatic cancer cells to TRAIL and celastrol-induced apoptosis.
Biol Cell. 105:414–429. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lee HW, Jang KS, Choi HJ, Jo A, Cheong JH
and Chun KH: Celastrol inhibits gastric cancer growth by induction
of apoptosis and autophagy. BMB Rep. 47:697–702. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Friedl P and Wolf K: Tumour-cell invasion
and migration: Diversity and escape mechanisms. Nat Rev Cancer.
3:362–374. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kannaiyan R, Hay HS, Rajendran P, Li F,
Shanmugam MK, Vali S, Abbasi T, Kapoor S, Sharma A, Kumar AP, et
al: Celastrol inhibits proliferation and induces chemosensitization
through down-regulation of NF-κB and STAT3 regulated gene products
in multiple myeloma cells. Br J Pharmacol. 164:1506–1521. 2011.
View Article : Google Scholar : PubMed/NCBI
|
